Kehinde Olaoye joined Hamad Bin Khalifa University College of Law as an assistant professor of commercial law in 2023. At Hamad Bin Khalifa University, she teaches commercial law and business association law. Before joining HBKU, she was a postdoctoral researcher and lecturer at the School of Law, City University of Hong Kong. Kehinde obtained degrees in law from the Chinese University of Hong Kong, King’s College London, and the University of Ibadan. She is qualified to practice law in Nigeria and has worked as an international arbitration and dispute resolution trainee in the Hong Kong office of an international law firm and as a commercial lawyer in Lagos, Nigeria.

Kehinde’s research has been published in leading international law journals including the American Journal of International Law, the European Journal of International Law, the World Trade Review, and the Journal of International Economic Law. She has served as the Managing Editor of the Asia Pacific Law Review and currently serves as a Book Review Editor for the Journal of World Investment and Trade.

Dr. Fatima Ahdash’s research interests lie in national security, family law, child rights and human rights and their various interactions. She holds a PhD from the London School of Economics (LSE) where she was awarded the prestigious Modern Law Review prize for her cutting-edge research. She has published in highly rated peer-reviewed journals and is currently writing a book (published by Routledge) on family regulation and counter-terrorism. She has acted as an expert consultant for the Council of Europe, the UN Special Rapporteur on Counter-Terrorism and Human Rights, UNICEF and various international organizations. Dr. Ahdash has worked with national and international NGOs including Rights and Security International and Reprieve in the area of national security and accountability. She has an LLM in Human Rights Law and an LLB from the LSE.

Ala Al-Fuqaha received his Ph.D. degree in Computer Engineering and Networking from the University of Missouri-Kansas City, Kansas City, MO, USA. He is currently a professor at the Information and Computing Technology division, College of Science and Engineering, Hamad Bin Khalifa University (HBKU). His research interests include the use of machine learning in general and deep learning in particular, this is in support of the data-driven and self-driven management of large-scale deployments of IoT and smart city infrastructure and services, ethical aspects of AI deployments, Wireless Vehicular Networks (VANETs), cooperation and spectrum access etiquette in cognitive radio networks, management, and planning of software-defined networks (SDN), and engineering education.

Prof. Al-Fuqaha played a key role in the design and development of the intelligent network management system for Dense Wavelength Division Multiplexed (DWDM) optical networks that was deployed at 6 sites (NRL, NSA, NASA, DIA, DISA, DARPA) in the Washington DC metropolitan area as part of the first all-optical network in the world (MONET project).

He is a senior member of the IEEE, a senior member of the ACM, and an ABET Program Evaluator (PEV) and commissioner. He serves on editorial boards of multiple journals, including IEEE Communications Letters, IEEE Network Magazine, and Springer AJSE. He also served as chair, co-chair, and technical program committee member of multiple international conferences, including IEEE VTC, IEEE Globecom, IEEE ICC, and IWCMC.

Dr. Markus Wenk is the Dean College of Health and Life Sciences. He fills other key roles at the moment; he is a Visiting Toh Chin Chye Professor and the National University of Singapore, an Editor-in-Chief, Encyclopaedia in Lipidomics (Springer), and a privatdozent in the faculty of science in the University of Basel.

Wenk has been interested in the structure and function of membranes since his time as a student at the Biozentrum of the University of Basel in 1994. During his time at Yale, he introduced new techniques to study how cells metabolize phospholipids. He's been a leader in using advanced methods to study lipids (lipidomics), earning recognition such as the European Lipid Science Award in 2018. Markus founded the Singapore Lipidomics Incubator (SLING) and the international Singapore Lipid Symposium (iSLS) at the National University of Singapore (NUS), focusing on innovation, education, and collaboration in lipid research. Lately, he's been working on incorporating precise molecular analysis into medical research for personalized health. 

Prior to his assumption of the role  in HBKU, Markus led the Department of Biochemistry at NUS from 2015 to 2022 and also directed the NUS Precision Medicine Translational Research Programme from 2020 to 2023.

Safa’s research is centered around safe AI, generative models (energy-based models) and reinforcement learning and motivated by applications in computer vision and health intelligence. Safa obtained her PhD in Electrical and Computer Engineering (ECE) from the University of Illinois at Urbana-Champaign working with Prof. Alexander Schwing. She graduated with Bachelor and Master degrees in Electrical Engineering and Information Technology from the Technical University of Munich. She obtained a Master degree in Computer Engineering from Virginia Tech advised by Prof. Sandeep Shukla. She was a visiting scholar at UC-Berkeley, where she worked on her Master thesis under the supervision of Prof. Alberto Sangiovanni Vincentelli and Prof. Andreas Herkersdorf.

Dr. Khouloud Mtibaa is a Laboratory Manager and Research Scientist at the College of Health and Life Sciences at Hamad Bin Khalifa University. Dr. Mtibaa obtained her PhD from Claude Bernard University Lyon 1, France. In 2013, she was valedictorian in her MSc in Exercise Sciences at the Higher Institute of Sports and Physical Education, Tunisia.

She worked at Qatar University as a teaching assistant in the Sports Science Program and the Physical Education Department. She is a certified health and fitness specialist and worked as a health and fitness Coach at Aspire Academy, Qatar.

Dr. Khalid A. Fakhro is the Chief Research Officer at Sidra Medicine and Chair of the Precision Medicine Program.

Dr Fakhro is also involved in capacity building and education via faculty appointments at Weill-Cornell Medicine - Qatar and at Hamad bin Khalifa University, where he teaches classes and mentors the next students in human genetics and genomic medicine.

As the CRO for Sidra Medicine, Dr. Fakhro is responsible for designing and implementing the healthcare organization’s ambitious research strategy to advance precision medicine for women and children in Qatar. The strategy aims to place Sidra Medicine among the top destinations for personalized care in the world, leveraging next-generation technologies to enhance disease diagnosis and implement advanced therapies for patients. Under his leadership, scientists in the Research Branch at Sidra Medicine, have made important strides in identifying genes and biomarkers of diseases affecting women and children, particularly those with rare conditions, and launched clinical trials that promise to deliver advanced therapies to patients in need. 

Prior to being appointed as CRO, Dr Fakhro led the Human Genetics Department at Sidra Medicine and launched the first Mendelian disease and precision medicine programs, heading these ambitious efforts where research in genomics and personalized medicine became embedded in the pathway of patient care. His lab specifically works on gene discovery in rare diseases (including autism), fertility genetics, structural variation, and genomic characterization of the Qatari population using multiple ‘omic technologies.
 

Muhammad Salman Mustansar Toor is a Postdoctoral Researcher at the College of Health and Life Sciences at Hamad Bin Khalifa University. Dr. Salman M Toor graduated in biomedical sciences with research in cancer biology and therapeutics from the University of Bradford and completed his PhD in tumor immunology from the University of Portsmouth, United Kingdom.

Dr. Toor worked at the College of Medicine and Health Sciences, United Arab Emirates University as a research assistant from 2014 to 2017 and joined Qatar Biomedical Research Institute as a research associate in 2017. He joined Dr. Omar Albagha’s group at the College of Health and Life Sciences, Hamad Bin Khalifa University in 2021.

Dr Toor’s research focuses on tumor immunology and his current research focuses on genomic medicine and understanding the genetic determinants of complex diseases with an emphasis on cardiovascular diseases and genetic risks for diabetes. With more than 50 research publications in reputed journals, Dr. Toor aspires to excel in academia and in biomedical research.

Throughout his career at Qatar Biomedical Research Institute, Dr. Alshaban has focused on applying epidemiological methods to investigate and evaluate the burden of autism spectrum disorder (ASD) on Qatari families and other families residing in Qatar. He began studying prevalence rates of ASD and all contributing risk factors associated with the disorder. From this, he and his team established the first ASD registry in Qatar funded by Qatar National Research Fund. The registry’s comprehensive database includes 110 variables regarding demographic, environmental, and clinical data of each diagnosed individual.

His current focus is the development of interdisciplinary research programs to improve early diagnosis, intervention, and treatment of ASD. He is working on the development of innovative screening and diagnostic tools using eye-tracking technology in collaboration with the Cleveland Clinic. Moreover, Dr. Alshaban’s work includes translating and validating the Arabic version of the Social Communication Questionnaire (SCQ), which is a golden standard tool for ASD screening. Additionally, he recently established a commercial partnership with the American company Argus Cognitive Inc. to co-develop the first Arabic digital phenotyping for social communication behaviors as a diagnostic tool for ASD, using machine learning and artificial intelligence to be used in conjunction with ADOS-2 diagnostic tool.

Dr. Gabriel Ghinita is an Associate Professor with the ICT Division, College of Science and Engineering, HBKU. Previously, he was a Tenured Associate Professor of Computer Science at UMass Boston, Visiting Professor at University of Southern California; and Research Associate with Purdue Cyber Center and Purdue Center for Education and Research in Information Assurance and Security (CERIAS).